MiNK Therapeutics, Inc. (INKT) vs Xilio Therapeutics, Inc. (XLO)
A side-by-side comparison of MiNK Therapeutics, Inc. and Xilio Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
INKT
MiNK Therapeutics, Inc.
$11.58HealthcareDelayed quote: Oct 6, 2026, 2:17 PM EDT
XLO
Xilio Therapeutics, Inc.
$9.26HealthcareDelayed quote: Oct 6, 2026, 2:07 PM EDT
Total return — INKT vs XLO
growth of $100 · dividends reinvested · last 5yINKT -90.3% (-37.3%/yr)XLO -95.9% (-47.3%/yr)INKT compounded faster over this window
INKT XLO
INKT vs XLO: by the numbers
- •XLO is the larger company ($61M vs $58M market cap).
- •Both run net losses; INKT's is the smaller (0.00% vs -34.06% net margin).
Metrics side by side
Valuation
| Metric | INKT | XLO |
|---|---|---|
| P/S ratio | N/A | 0.95 |
| P/B ratio | N/A | 0.84 |
Profitability
| Metric | INKT | XLO |
|---|---|---|
| Gross margin | 0.00% | 99.46% |
| Operating margin | 0.00% | -95.92% |
| Net margin | 0.00% | -34.06% |
| ROE | N/A | -30.21% |
| ROIC | -604.20% | -26.13% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.